Universitat de València-ko ikertzaileekin lankidetzan egindako argitalpenak (11)

2021

  1. Gender Differences in the Presentation and Outcomes of Hospitalized Patients With COVID-19

    Journal of hospital medicine, Vol. 16, Núm. 6, pp. 349-352

2020

  1. Prognostic Impact of Hyponatremia and Hypernatremia in COVID-19 Pneumonia. A HOPE-COVID-19 (Health Outcome Predictive Evaluation for COVID-19) Registry Analysis

    Frontiers in Endocrinology, Vol. 11

2019

  1. Effects of immunonutrition in advanced human immunodeficiency virus disease: A randomized placebo-controlled clinical trial (Promaltia study)

    Clinical Infectious Diseases, Vol. 68, Núm. 1, pp. 120-130

  2. Modulation of saliva microbiota through prebiotic intervention in HIV-Infected individuals

    Nutrients, Vol. 11, Núm. 6

2018

  1. Effects of HIV, antiretroviral therapy and prebiotics on the active fraction of the gut microbiota

    AIDS, Vol. 32, Núm. 10, pp. 1229-1237

  2. Interplay between gut microbiota metabolism and inflammation in HIV infection

    ISME Journal, Vol. 12, Núm. 8, pp. 1964-1976

2017

  1. Cardiovascular toxicity of abacavir: A clinical controversy in need of a pharmacological explanation

    AIDS, Vol. 31, Núm. 13, pp. 1781-1795

  2. The effects of prebiotics on microbial dysbiosis, butyrate production and immunity in HIV-infected subjects

    Mucosal Immunology, Vol. 10, Núm. 5, pp. 1279-1293

2016

  1. Gut Bacteria Metabolism Impacts Immune Recovery in HIV-infected Individuals

    EBioMedicine, Vol. 8, pp. 203-216

  2. HIV infection results in metabolic alterations in the gut microbiota different from those induced by other diseases

    Scientific Reports, Vol. 6

2015

  1. Altered metabolism of gut microbiota contributes to chronic immune activation in HIV-infected individuals

    Mucosal Immunology, Vol. 8, Núm. 4, pp. 760-772